Noa Biran

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 7

Top Venues

American journal of hematology

EJHaem

JMIR formative research

This page only lists publications with an associated author ORCID identifier.

Publications

Muhamed Baljevic, Cristina Gasparetto, Gary J Schiller, Sascha A Tuchman, Natalie S Callander, Suzanne Lentzsch, Jorge Monge, Rami Kotb, Nizar J Bahlis, Darrell White, Christine I Chen, Heather J Sutherland, Sumit Madan, Richard LeBlanc, Michael Sebag, Christopher P Venner, William I Bensinger, Noa Biran, Andrew DeCastro, Dane R Van Domelen, Chris Zhang, Jatin J Shah, Sharon Shacham, Michael G Kauffman, Ohad S Bentur, Brea Lipe
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment. EJHaem 3 (4) (2022)
Noa Biran, Elli Gourna Paleoudis, Rena Feinman, David H Vesole, Joshua Zenreich, Shuqi Wang, Jaeil Ahn, Meena B Bansal, Scott Douglas Rowley, Michele L Donato, Andrew L Pecora, Joshua Richter, Palka Anand, Laura McBride, Kristin Ivanovski, Robert Korngold, David S Siegel
Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma. American journal of hematology 96 (11) (2021)
Noa Biran, Wanting Zhai, Roxanne E Jensen, Jeanne S Mandelblatt, Susan Kumka, Rashmi Unawane, Kristi D Graves, David H Vesole, David S Siegel, Arnold L Potosky
Patient-reported outcomes following autologous stem cell transplant for patients with multiple myeloma. EJHaem 2 (3) (2021)
Noa Biran, Binod Dhakal, Suzanne Lentzsch, David Siegel, Saad Z Usmani, Adriana Rossi, Cara A Rosenbaum, Divaya Bhutani, David H Vesole, Cesar Rodriguez, Ajay K Nooka, Frits van Rhee, Lisette Stork-Sloots, Femke de Snoo, Pritish K Bhattacharyya, Durga Prasad Dash, Sena Zümrütçü, Martin H van Vliet, Parameswaran Hari, Ruben Niesvizky
Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trial. EJHaem 2 (3) (2021)
Noa Biran, Robin C Anthony Kouyaté, Emre Yucel, Gillian E McGovern, Antoinette M Schoenthaler, Olivia G Durling, Rashmi Unawane, Andrew Schutt, Sumeet Panjabi
Adaptation and Evaluation of a Symptom-Monitoring Digital Health Intervention for Patients With Relapsed and Refractory Multiple Myeloma: Pilot Mixed-Methods Implementation Study. JMIR formative research 4 (11) (2020)
Robert Frank Cornell, Parameswaran Hari, Shijie Tang, Noa Biran, Natalie Callander, Ajai Chari, Saurabh Chhabra, Mark A Fiala, Zhubin Gahvari, Ujjawal Gandhi, Kelly Godby, Ridhi Gupta, Sundar Jagannath, Megan Jagosky, Yubin Kang, Ankit Kansagra, Michael Kauffman, Saranya Kodali, Shaji K Kumar, Arjun Lakshman, Michaela Liedtke, Sagar Lonial, Xiwen Ma, Ehsan Malek, Joshua Mansour, Elizabeth F McGehee, Amarendra Neppalli, Barry Paul, Paul Richardson, Emma C Scott, Sharon Shacham, Jatin Shah, David S Siegel, Elvira Umyarova, Saad Z Usmani, William Varnado, Ravi Vij, Luciano Costa
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH. American journal of hematology 96 (1) (2020)
Noa Biran, David Siegel, Jesus G Berdeja, Noopur Raje, Robert Frank Cornell, Melissa Alsina, Tibor Kovacsovics, Belle Fang, Amy S Kimball, Ola Landgren
Weekly carfilzomib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A phase 1b study. American journal of hematology 94 (7) (2019)

Noa Biran.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Noa Biran